Fund Holdings — Valence8 US LP

Total Portfolio Value
$229.44M
Total Bought
$33.09M
Total Sold
$2.33M
Net Transaction
+$30.76M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ISHARES TR
MSCI USA QLT FCT
301,048337,472+36,42451,40760,50926.37%+9,102
ISHARES TR
MSCI INTL QUALTY
892,1931,026,290+134,09734,84042,58118.56%+7,741
INVESCO QQQ TR76,71188,149+11,43836,75343,02318.75%+6,270
ISHARES TR399,186399,186021,17322,96510.01%+1,792
JAZZ PHARMACEUTICALS PLC(JAZZ)08,969+8,96909990.44%+999
BRISTOL-MYERS SQUIBB CO(BMY)017,785+17,78509200.40%+920
SELECT SECTOR SPDR TR
ST STR STAPL ETF
168,300165,267-3,03312,88813,7175.98%+829
VANGUARD INDEX FDS100,00396,630-3,37316,04116,8697.35%+827
ASCENDIS PHARMA A/S(ASND)04,585+4,58506850.30%+685
INSMED INC(INSM)07,865+7,86505740.25%+574
INDIVIOR PLC057,293+57,29305640.25%+564
ELI LILLY & CO(LLY)0633+63305610.24%+561
ARGENX SE(ARGX)0953+95305170.23%+517
SOLENO THERAPEUTICS INC09,706+9,70604900.21%+490
KEROS THERAPEUTICS INC(KROS)08,025+8,02504660.20%+466
NUVALENT INC04,115+4,11504210.18%+421
SELECT SECTOR SPDR TR
ST STR UTIL ETF
55,58851,940-3,6483,7884,1961.83%+408
ISHARES INC
MSCI JAPAN ETF
108,634108,63407,4137,7723.39%+358
JANUX THERAPEUTICS INC(JANX)07,857+7,85703570.16%+357
CRINETICS PHARMACEUTICALS IN(CRNX)06,684+6,68403420.15%+342
TYRA BIOSCIENCES INC(TYRA)013,188+13,18803100.14%+310
APOGEE THERAPEUTICS INC(APGE)05,240+5,24003080.13%+308
VAXCYTE INC(PCVX)02,468+2,46802820.12%+282
INTELLIA THERAPEUTICS INC(NTLA)013,020+13,02002680.12%+268
ISHARES TR
MSCI UK ETF NEW
216,934209,344-7,5907,5677,8323.41%+265
VIR BIOTECHNOLOGY INC(VIR)033,650+33,65002520.11%+252
BLUEPRINT MEDICINES CORP02,618+2,61802420.11%+242
ULTRAGENYX PHARMACEUTICAL IN(RARE)04,241+4,24102360.10%+236
ENANTA PHARMACEUTICALS INC(ENTA)019,939+19,93902070.09%+207
RELAY THERAPEUTICS INC(RLAY)026,200+26,20001850.08%+185
ZEVRA THERAPEUTICS INC(ZVRA)021,596+21,59601500.07%+150
ERASCA INC(ERAS)046,923+46,92301280.06%+128
SOLID BIOSCIENCES INC015,728+15,72801100.05%+110
VISTAGEN THERAPEUTICS INC(VTGN)034,376+34,37601030.05%+103
ZURA BIO LTD(ZURA)017,495+17,4950710.03%+71
ALECTOR INC014,708+14,7080690.03%+69
ELIEM THERAPEUTICS INC(CLYM)012,045+12,0450610.03%+61
LEAP THERAPEUTICS INC(CYPH)018,511+18,5110480.02%+48
NEKTAR THERAPEUTICS(NKTR)026,107+26,1070340.01%+34
KEZAR LIFE SCIENCES INC021,136+21,1360160.01%+16
Page 1 of 1
Valence8 US LP — 13F Holdings — Q3 2024 | TickerTrail